The 3 analysts offering 12-month price forecasts for DiaMedica Therapeutics Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 14.00. The median estimate represents a +160.71% increase from the last price of 5.37.
The current consensus among 3 polled investment analysts is to Buy stock in DiaMedica Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.15
Reporting Date Nov 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.